Search research articles
Contact Us
Filters
Showing results (211-220 of 216) with videos related to
Page
of 22
Sort By:
You have reached the last page of results.
This site can display upto 216 results.
Molecular Cancer Therapeutics
|
December 28, 2020
The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies
Sruthy Varghese, Snigdha Pramanik, Leila J Williams, et al.
Animal : an International Journal of Animal Bioscience
|
January 7, 2025
Genomic insights into the specialisation and selection of the Jinding duck
H Chen, Y Huang, J Xue, et al.
NPJ Precision Oncology
|
July 27, 2025
IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer
Nicole M Kettner, Tuyen N Bui, Juliana Navarro-Yepes, et al.
Transplantation and Cellular Therapy
|
April 11, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report
Carrie L Kitko, Joseph Pidala, Hélène M Schoemans, et al.
Zhonghua Yi Xue Za Zhi
|
December 28, 2020
[Efficacy and safety of Kangbingdu granules in the treatment of influenza: a randomized, double-blind, double-dummy, positive-drug parallel control multicenter clinical trial]
Y Nong, J T Lin, X W Sun, et al.
Gastroenterology
|
July 29, 2019
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet
Yongde Luo, Yaying Yang, Muyun Liu, et al.
Page
of 22
Search research articles
Search
Showing results (211-220 of 216) with videos related to
Sort By:
Page
of 22
You have reached the last page of results.
This site can display upto 216 results.
Molecular Cancer Therapeutics
|
December 28, 2020
The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies
Sruthy Varghese, Snigdha Pramanik, Leila J Williams, et al.
Animal : an International Journal of Animal Bioscience
|
January 7, 2025
Genomic insights into the specialisation and selection of the Jinding duck
H Chen, Y Huang, J Xue, et al.
NPJ Precision Oncology
|
July 27, 2025
IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer
Nicole M Kettner, Tuyen N Bui, Juliana Navarro-Yepes, et al.
Transplantation and Cellular Therapy
|
April 11, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report
Carrie L Kitko, Joseph Pidala, Hélène M Schoemans, et al.
Zhonghua Yi Xue Za Zhi
|
December 28, 2020
[Efficacy and safety of Kangbingdu granules in the treatment of influenza: a randomized, double-blind, double-dummy, positive-drug parallel control multicenter clinical trial]
Y Nong, J T Lin, X W Sun, et al.
Gastroenterology
|
July 29, 2019
Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet
Yongde Luo, Yaying Yang, Muyun Liu, et al.
Page
of 22